Biomea Fusion, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Biomea Fusion, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, is 1.3 times its market value (net cash). Higher than 91% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-48.2×Operating cash was negative last year, while some debt falls due within a year.
Lower than 72% of Healthcare companies in United States.
Cash Cushion Ratio
1.3× cashCash, after subtracting all debt, is 1.3 times its market value (net cash).
Higher than 91% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Biomea Fusion, Inc. made a loss over the last year. Biomea Fusion, Inc. owes $0.67 for every $1 it owns. Biomea Fusion, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossBiomea Fusion, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
3.48The share price is 3.48 times Biomea Fusion, Inc.'s book value per share, higher than 61% of Healthcare companies in United States.
Market cap
$42 MThe total market value of all of Biomea Fusion, Inc.'s shares at today's price (share price × number of shares), smaller than 76% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$12 MWhat Biomea Fusion, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.17Net worth divided by the number of shares. The share price of $0.58 is 3.5 times this, which is the P/B above.
Return on equity (ROE)
-164.1%Biomea Fusion, Inc. lost 164.1% of its shareholders' money over the last year, lower than 81% of Healthcare companies in United States.
Owes vs Owns
0.67×Biomea Fusion, Inc. owes $0.67 for every $1 it owns (moderate), higher than 70% of Healthcare companies in United States.
Dividend yield
NoneBiomea Fusion, Inc. does not currently pay a dividend.
Profit growth
LossBiomea Fusion, Inc. made a loss in each of the last two years.
Cash vs debt
Net cashBiomea Fusion, Inc. held $54 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Biomea Fusion, Inc.: $42 M ÷ $12 M (30 Jun 2026) = 3.5.
What is Biomea Fusion, Inc.'s return on equity?
Biomea Fusion, Inc. lost 164.1% of its shareholders' money over the last year, lower than 81% of Healthcare companies in United States.
How much does Biomea Fusion, Inc. owe compared with what it owns?
Biomea Fusion, Inc. owes $0.67 for every $1 it owns (moderate), higher than 70% of Healthcare companies in United States.
Does Biomea Fusion, Inc. pay a dividend?
No. Biomea Fusion, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.